{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:13:28Z","timestamp":1791598408863,"version":"4.3.4"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.phrs.2024.107456","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:42:13Z","timestamp":1728502933000},"page":"107456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?"],"prefix":"10.1016","volume":"209","author":[{"given":"Lucrezia Irene Maria","family":"Campagnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Varesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Morozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ricevuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107456_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib2","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.3390\/app13105881","article-title":"Why is multiple sclerosis more frequent in women? Role of the immune system and of oral and gut microbiota","volume":"13","author":"D\u2019Anca","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.phrs.2024.107456_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","article-title":"Blood-brain barrier disruption in multiple sclerosis","volume":"9","author":"Minagar","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2024.107456_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp-2017-316011","article-title":"Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier","volume":"89","author":"Spencer","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107456_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/brainsci7070078","article-title":"Multiple sclerosis: immunopathology and treatment update","volume":"7","author":"Dargahi","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.phrs.2024.107456_bib7","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2024.107456_bib8","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3390\/microorganisms10122436","article-title":"The role of the gut microbiome in psychiatric disorders","volume":"10","author":"Andrioaie","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.phrs.2024.107456_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/nu14030668","article-title":"The potential role of gut microbiota in Alzheimer\u2019s disease: from diagnosis to treatment","volume":"14","author":"Varesi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib10","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.3390\/ijms232012289","article-title":"The interplay between gut microbiota and Parkinson\u2019s disease: implications on diagnosis and treatment","volume":"23","author":"Varesi","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106799","article-title":"The brain-gut-microbiota interplay in depression: a key to design innovative therapeutic approaches","volume":"192","author":"Varesi","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107456_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.autrev.2017.11.019","article-title":"Combined therapies to treat complex diseases: the role of the gut microbiota in multiple sclerosis","volume":"17","author":"Calvo-Barreiro","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2024.107456_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib14","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/cells12131760","article-title":"The role of gut microbiome in the pathogenesis of multiple sclerosis and related disorders","volume":"12","author":"Dunalska","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107456_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2024.107456_bib16","doi-asserted-by":"crossref","first-page":"53829","DOI":"10.18632\/oncotarget.17754","article-title":"Microbiota-gut-brain axis and the central nervous system","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2024.107456_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250229","article-title":"Microbiota, diet, and the gut\u2013brain axis in multiple sclerosis and stroke","volume":"53","author":"Diaz-Marugan","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib18","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7502","article-title":"Factors affecting the composition of the gut microbiota, and its modulation","volume":"7","author":"Hasan","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2024.107456_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104621","article-title":"Exercise, diet and stress as modulators of gut microbiota: implications for neurodegenerative diseases","volume":"134","author":"Gubert","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107456_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104856","article-title":"Targeting the microbiota in pharmacology of psychiatric disorders","volume":"157","author":"Pascale","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107456_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1092118","article-title":"Gut-joint axis: gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways","volume":"13","author":"Romero-Figueroa","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phrs.2024.107456_bib22","doi-asserted-by":"crossref","first-page":"14650","DOI":"10.3390\/ijms232314650","article-title":"Pathophysiology of type 1 diabetes and gut microbiota role","volume":"23","author":"Del Chierico","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2024.107456_bib24","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/nu11112714","article-title":"Undigested food and gut microbiota may cooperate in the pathogenesis of neuroinflammatory diseases: a matter of barriers and a proposal on the origin of organ specificity","volume":"11","author":"Riccio","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The central nervous system and the gut microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107456_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1113\/JP273106","article-title":"Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration","volume":"595","author":"Dinan","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2024.107456_bib27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/cmi.12585","article-title":"Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis","volume":"18","author":"Bauer","year":"2016","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.phrs.2024.107456_bib28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107456_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/376023","article-title":"Anorectal Dysfunction in Multiple Sclerosis: A Systematic Review","volume":"2012","author":"Nusrat","year":"2012","journal-title":"ISRN Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4065\/75.8.802","article-title":"Concurrence of inflammatory bowel disease and multiple sclerosis","volume":"75","author":"Kimura","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2024.107456_bib31","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/BF02100148","article-title":"Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability","volume":"41","author":"Yacyshyn","year":"1996","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2024.107456_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143774","article-title":"Targeting the gut to treat multiple sclerosis","volume":"131","author":"Ghezzi","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2024.107456_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72197-y","article-title":"Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract","volume":"10","author":"Johanson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib34","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1038\/s41598-019-43356-7","article-title":"The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models","volume":"9","author":"Gandy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib35","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/acschemneuro.0c00695","article-title":"Gut microbiota changes in experimental autoimmune encephalomyelitis and cuprizone mice models","volume":"12","author":"Moles","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/19490976.2017.1353843","article-title":"A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis","volume":"8","author":"Colpitts","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2024.107456_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia xiva and iv clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2024.107456_bib38","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700492","article-title":"High frequency of intestinal T(h)17 cells correlates with microbiota alterations and disease activity in multiple sclerosis","volume":"3","author":"Cosorich","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2024.107456_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107456_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103798","article-title":"Alterations of host-gut microbiome interactions in multiple sclerosis","volume":"76","author":"Cantoni","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.phrs.2024.107456_bib42","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2024.107456_bib43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/ene.13026","article-title":"The US network of pediatric ms centers, gut microbiota in early pediatric multiple sclerosis: a case\u2212control study","volume":"23","author":"Tremlett","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12866-019-1685-2","article-title":"Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity","volume":"19","author":"Kozhieva","year":"2019","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.phrs.2024.107456_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acn3.51004","article-title":"Gut microbiome variation is associated to multiple sclerosis phenotypic subtypes","volume":"7","author":"Reynders","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib46","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ana.26084","article-title":"Gut microbiome in progressive multiple sclerosis","volume":"89","author":"Cox","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib47","doi-asserted-by":"crossref","first-page":"22402","DOI":"10.1073\/pnas.2011703117","article-title":"Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis","volume":"117","author":"Takewaki","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2024.107456_bib48","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52894-z","article-title":"Gut microbiome of treatment-na\u00efve MS patients of different ethnicities early in disease course","volume":"9","author":"Ventura","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib50","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","article-title":"Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis","volume":"183","author":"Ochoa-Rep\u00e1raz","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4161\/gmic.1.2.11515","article-title":"Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora","volume":"1","author":"Ochoa-Rep\u00e1raz","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2024.107456_bib52","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107456_bib53","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.1000082107","article-title":"Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis","volume":"108","author":"Lee","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2024.107456_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-2634-9","article-title":"Gut microorganisms act together to exacerbate inflammation in spinal cords","volume":"585","author":"Miyauchi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107456_bib55","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2024.107456_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin. Trans. Imm"},{"key":"10.1016\/j.phrs.2024.107456_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2024.107456_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107456_bib59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2024.107456_bib60","article-title":"Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis","volume":"2","author":"Farrokhi","year":"2013","journal-title":"Clin. amp; Trans. Imm"},{"key":"10.1016\/j.phrs.2024.107456_bib61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","article-title":"Linking the human gut microbiome to inflammatory cytokine production capacity","volume":"167","author":"Schirmer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107456_bib62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/19490976.2017.1349041","article-title":"Gut microbiome in multiple sclerosis: the players involved and the roles they play","volume":"8","author":"Shahi","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2024.107456_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.intimp.2013.07.013","article-title":"Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia","volume":"17","author":"Jantaratnotai","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2024.107456_bib64","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.3390\/ijms21175982","article-title":"Bile acid signaling in neurodegenerative and neurological disorders","volume":"21","author":"Grant","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib65","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2249.2003.02053.x","article-title":"Monocyte-derived cytokines in multiple sclerosis","volume":"131","author":"Filion","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib66","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1172\/JCI129401","article-title":"Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation","volume":"130","author":"Bhargava","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2024.107456_bib67","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216941120","article-title":"Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system","volume":"120","author":"Gr\u00fcter","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2024.107456_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.578648","article-title":"Human Commensal Prevotella histicola Ameliorates Disease as Effectively as Interferon-Beta in the Experimental Autoimmune Encephalomyelitis","volume":"11","author":"Shahi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099411","article-title":"The Intestinal Archaea Methanosphaera stadtmanae and Methanobrevibacter smithii Activate Human Dendritic Cells","volume":"9","author":"Bang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2024.107456_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2011.00166","article-title":"Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila","volume":"2","author":"Derrien","year":"2011","journal-title":"Front. Micro"},{"key":"10.1016\/j.phrs.2024.107456_bib71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.chom.2019.10.008","article-title":"Oral Administration of miR-30d from Feces of MS Patients Suppresses MS-like Symptoms in Mice by Expanding Akkermansia muciniphila","volume":"26","author":"Liu","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.phrs.2024.107456_bib72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12883-016-0703-3","article-title":"Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls","volume":"16","author":"Tremlett","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2016.02.042","article-title":"Gut microbiota composition and relapse risk in pediatric MS: A pilot study","volume":"363","author":"Tremlett","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2024.107456_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11940-015-0344-7","article-title":"The Gut Microbiome in Multiple Sclerosis","volume":"17","author":"Mielcarz","year":"2015","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav."},{"key":"10.1016\/j.phrs.2024.107456_bib76","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2174\/1570159X19666210629145351","article-title":"Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications","volume":"20","author":"Wang","year":"2022","journal-title":"CN"},{"key":"10.1016\/j.phrs.2024.107456_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.12688\/f1000research.20510.1","article-title":"All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases","volume":"9","author":"Fasano","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2024.107456_bib78","article-title":"One more role for the gut: microbiota and blood brain barrier","volume":"15","author":"Michel","year":"2016","journal-title":"Ann. Transl. Med 4"},{"key":"10.1016\/j.phrs.2024.107456_bib79","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.7150\/ijbs.79430","article-title":"The role of gut microbiota in T cell immunity and immune mediated disorders","volume":"19","author":"Shim","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107456_bib80","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-017-0582-3","article-title":"Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis","volume":"15","author":"Buscarinu","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2024.107456_bib81","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/1352458516652498","article-title":"Altered intestinal permeability in patients with relapsing\u2013remitting multiple sclerosis: A pilot study","volume":"23","author":"Buscarinu","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2024.107456_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106335","article-title":"Intestinal Barrier Dysfunction Develops at the Onset of Experimental Autoimmune Encephalomyelitis, and Can Be Induced by Adoptive Transfer of Auto-Reactive T Cells","volume":"9","author":"Nouri","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2024.107456_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12017-019-08547-5","article-title":"Gut Microbiota Disorder, Gut Epithelial and Blood\u2013Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways","volume":"21","author":"Welcome","year":"2019","journal-title":"Neuromol Med"},{"key":"10.1016\/j.phrs.2024.107456_bib84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2024.107456_bib85","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.3390\/ijerph18094621","article-title":"Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing\u2013Remitting Multiple Sclerosis","volume":"18","author":"Pellizoni","year":"2021","journal-title":"IJERPH"},{"key":"10.1016\/j.phrs.2024.107456_bib86","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0165-0173(01)00102-3","article-title":"Molecular and cellular permeability control at the blood\u2013brain barrier","volume":"36","author":"Gloor","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.phrs.2024.107456_bib87","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","article-title":"Disruption of central nervous system barriers in multiple sclerosis","volume":"1812","author":"Alvarez","year":"2011","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2024.107456_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib89","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.celrep.2017.07.031","article-title":"Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease","volume":"20","author":"Mangalam","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib90","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","article-title":"Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine","volume":"4","author":"Ivanov","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.phrs.2024.107456_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7904821","article-title":"Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?","volume":"2017","author":"Adamczyk-Sowa","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2024.107456_bib92","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Baecher-Allan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107456_bib93","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"Machado-Santos","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2024.107456_bib94","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.1073\/pnas.0909122107","article-title":"Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota","volume":"107","author":"Round","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2024.107456_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/srep37344","article-title":"Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis","volume":"6","author":"Branton","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib96","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/1028415X.2019.1681088","article-title":"Effect of nutrition on neurodegenerative diseases. A systematic review","volume":"24","author":"Bianchi","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11910-017-0732-3","article-title":"Dietary Interventions and Multiple Sclerosis","volume":"17","author":"Altowaijri","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib98","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/brainsci10040234","article-title":"Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know","volume":"10","author":"Boziki","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.phrs.2024.107456_bib99","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1515\/revneuro-2021-0146","article-title":"Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases","volume":"33","author":"Gates","year":"2022","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1272338","article-title":"Editorial: Nutrition and neurodegenerative diseases: insights and perspectives on prevention strategies","volume":"10","author":"Liu","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.phrs.2024.107456_bib101","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3390\/nu15132978","article-title":"The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update","volume":"15","author":"Sangha","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and Multiple Sclerosis: A Comprehensive Review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.phrs.2024.107456_bib103","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005257","article-title":"Sun exposure over the life course and associations with multiple sclerosis","volume":"90","author":"Tremlett","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2024.107456_bib104","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/immuno2030029","article-title":"Vitamin D Receptor and Its Influence on Multiple Sclerosis Risk and Severity: From Gene Polymorphisms to Protein Expression","volume":"2","author":"Pistono","year":"2022","journal-title":"Immuno"},{"key":"10.1016\/j.phrs.2024.107456_bib105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib106","article-title":"Vitamin D and neurodegenerative diseases","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2024.107456_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125836","article-title":"Treatment with Vitamin D\/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis","volume":"10","author":"Chiuso-Minicucci","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2024.107456_bib108","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/ijms22041914","article-title":"Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol","volume":"22","author":"Mimura","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib109","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/jnnp.2004.056499","article-title":"A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis","volume":"76","author":"Wingerchuk","year":"2005","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107456_bib110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcn\/86.3.645","article-title":"Safety of vitamin D3 in adults with multiple sclerosis","volume":"86","author":"Kimball","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2024.107456_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015235","article-title":"Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis","volume":"5","author":"Smolders","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2024.107456_bib112","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00415-011-5980-6","article-title":"Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial","volume":"258","author":"Steffensen","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib113","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1745-6215-13-15","article-title":"Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial","volume":"13","author":"D\u00f6rr","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.phrs.2024.107456_bib114","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/1352458511434607","article-title":"Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial","volume":"18","author":"Kampman","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2024.107456_bib115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-H\u00e4nninen","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107456_bib116","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2015.05.022","article-title":"Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial","volume":"285","author":"Toghianifar","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2024.107456_bib117","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008445","article-title":"on behalf of the SOLAR Study Group, Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon \u03b2-1a","volume":"93","author":"Hupperts","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2024.107456_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101957","article-title":"High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial","volume":"59","author":"Cassard","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.phrs.2024.107456_bib119","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/nu12030783","article-title":"Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats","volume":"12","author":"Feige","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77806-4","article-title":"The potential role of vitamin D supplementation as a gut microbiota modifier in healthy individuals","volume":"10","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib121","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clnesp.2019.10.020","article-title":"The effects of high doses of vitamin D on the composition of the gut microbiome of adolescent girls","volume":"35","author":"Tabatabaeizadeh","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.phrs.2024.107456_bib122","doi-asserted-by":"crossref","first-page":"551","DOI":"10.21873\/anticanres.13984","article-title":"The Effect of Various Doses of Oral Vitamin D 3 Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study","volume":"40","author":"Charoenngam","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phrs.2024.107456_bib123","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/JIM.0000000000000192","article-title":"Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators","volume":"63","author":"Cantarel","year":"2015","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.phrs.2024.107456_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954845","article-title":"Intrinsic dietary fibers and the gut microbiome: Rediscovering the benefits of the plant cell matrix for human health","volume":"13","author":"Puhlmann","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-food-081315-032749","article-title":"A Critical Look at Prebiotics Within the Dietary Fiber Concept","volume":"7","author":"Verspreet","year":"2016","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.phrs.2024.107456_bib126","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ni.3713","article-title":"Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes","volume":"18","author":"Mari\u00f1o","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib127","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107456_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28839-3","article-title":"Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status","volume":"8","author":"Berer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-019-1552-y","article-title":"Butyrate suppresses demyelination and enhances remyelination","volume":"16","author":"Chen","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107456_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102957","article-title":"The immunomodulatory roles of the gut microbiome in autoimmune diseases of the central nervous system: Multiple sclerosis as a model","volume":"137","author":"Hoffman","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2024.107456_bib131","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jnc.14032","article-title":"Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis","volume":"141","author":"Chevalier","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2024.107456_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111328","article-title":"Inhibition of Th1 activation and differentiation by dietary guar gum ameliorates experimental autoimmune encephalomyelitis","volume":"40","author":"Fettig","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib133","doi-asserted-by":"crossref","first-page":"1857515","DOI":"10.1080\/19490976.2020.1857515","article-title":"Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota","volume":"12","author":"Lu","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2024.107456_bib134","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3945\/an.116.014191","article-title":"Influence of Diet in Multiple Sclerosis: A Systematic Review","volume":"8","author":"Bagur","year":"2017","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.phrs.2024.107456_bib135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-023-02772-3","article-title":"Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK Biobank prospective cohort study","volume":"21","author":"Shannon","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.phrs.2024.107456_bib136","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1871530314666140922153350","article-title":"The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases","volume":"14","author":"Casas","year":"2014","journal-title":"EMIDDT"},{"key":"10.1016\/j.phrs.2024.107456_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101869","article-title":"Dietary patterns and biomarkers of oxidative stress and inflammation: A systematic review of observational and intervention studies","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2024.107456_bib138","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/00207454.2020.1750398","article-title":"The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial","volume":"131","author":"Mousavi-Shirazi-Fard","year":"2021","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib139","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/1028415X.2019.1580831","article-title":"Association of dietary patterns with systemic inflammation, quality of life, disease severity, relapse rate, severity of fatigue and anthropometric measurements in MS patients","volume":"23","author":"Moravejolahkami","year":"2020","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101403","article-title":"Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study","volume":"36","author":"Katz Sand","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.phrs.2024.107456_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102636","article-title":"Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis","volume":"47","author":"Esposito","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.phrs.2024.107456_bib142","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/MNM-210557","article-title":"A Mediterranean-type diet improved systemic inflammation in multiple sclerosis patients, as compared to the traditional Iranian diet: A single-center randomized controlled trial","volume":"14","author":"Mirashrafi","year":"2021","journal-title":"MNM"},{"key":"10.1016\/j.phrs.2024.107456_bib143","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1017\/S000711452100307X","article-title":"Modified Mediterranean diet v. traditional Iranian diet: efficacy of dietary interventions on dietary inflammatory index score, fatigue severity and disability in multiple sclerosis patients","volume":"128","author":"Bohlouli","year":"2022","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2024.107456_bib144","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/13524585221127414","article-title":"Mediterranean diet is linked to less objective disability in multiple sclerosis","volume":"29","author":"Katz Sand","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2024.107456_bib145","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1080\/10942912.2020.1840390","article-title":"Potential of modified Mediterranean diet to improve quality of life and fatigue severity in multiple sclerosis patients: a single-center randomized controlled trial","volume":"23","author":"Moravejolahkami","year":"2020","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.phrs.2024.107456_bib146","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neurop.2021.07.001","article-title":"Eating habits of patients with multiple sclerosis in three different countries: China, Spain and Cuba","volume":"1","author":"Zhang","year":"2021","journal-title":"Neurol. Perspect."},{"key":"10.1016\/j.phrs.2024.107456_bib147","doi-asserted-by":"crossref","DOI":"10.18502\/cjn.v19i3.5424","article-title":"A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue","author":"Razeghi-Jahromi","year":"2021","journal-title":"CJN"},{"key":"10.1016\/j.phrs.2024.107456_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104060","article-title":"Association of self-reported adherence to the Mediterranean diet with anthropometric indices, comorbidities, and degree of disability in patients with multiple sclerosis","volume":"66","author":"Farzinmehr","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.phrs.2024.107456_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.882426","article-title":"Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy","volume":"9","author":"Felicetti","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.phrs.2024.107456_bib150","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/nu11102448","article-title":"Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models","volume":"11","author":"Conde","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960761","article-title":"D. Otaegui, The international Multiple Sclerosis Microbiome Study Consortium, Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis","volume":"13","author":"Moles","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib152","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The Controversial Role of Human Gut Lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.phrs.2024.107456_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1087126","article-title":"Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis","volume":"13","author":"Wingo","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib154","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cmet.2018.05.006","article-title":"Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota","volume":"27","author":"Cignarella","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107456_bib155","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.celrep.2016.05.009","article-title":"A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib156","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4595","article-title":"Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis","volume":"7","author":"Jensen","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2024.107456_bib157","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13311-017-0588-x","article-title":"The \u201cGut Feeling\u201d: Breaking Down the Role of Gut Microbiome in Multiple Sclerosis","volume":"15","author":"Freedman","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2024.107456_bib158","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3389\/fimmu.2017.01391","article-title":"Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study","volume":"8","author":"Saresella","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib159","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107456_bib160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4014\/jmb.1906.06064","article-title":"Role of Probiotics in Human Gut Microbiome-Associated Diseases","volume":"29","author":"Kim","year":"2019","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107456_bib161","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002658","article-title":"Clinical Uses of Probiotics","volume":"95","author":"Islam","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2024.107456_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body","volume":"12","author":"Cristofori","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib163","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ijerph19010037","article-title":"From Pre- and Probiotics to Post-Biotics: A Narrative Review","volume":"19","author":"Scarpellini","year":"2021","journal-title":"IJERPH"},{"key":"10.1016\/j.phrs.2024.107456_bib164","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/postgradmedj-2015-133285","article-title":"Gut microbiota, obesity and diabetes","volume":"92","author":"Patterson","year":"2016","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.phrs.2024.107456_bib165","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/cells11182827","article-title":"Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention","volume":"11","author":"Campagnoli","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107456_bib166","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.3390\/molecules27113402","article-title":"The Role of Microbiome in Brain Development and Neurodegenerative Diseases","volume":"27","author":"Nandwana","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2024.107456_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114195","article-title":"The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis","volume":"159","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107456_bib168","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/microorganisms11041083","article-title":"Probiotics for Neurodegenerative Diseases: A Systemic Review","volume":"11","author":"Ojha","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.phrs.2024.107456_bib169","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.3390\/molecules25214891","article-title":"Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders","volume":"25","author":"Shahbazi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2024.107456_bib170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clim.2013.01.001","article-title":"Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response","volume":"146","author":"Kwon","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib171","doi-asserted-by":"crossref","first-page":"35","DOI":"10.32598\/bcn.2021.1955.1","article-title":"Oral Administration of Probiotic Enterococcus durans to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice","volume":"13","author":"Samani","year":"2022","journal-title":"BCN"},{"key":"10.1016\/j.phrs.2024.107456_bib172","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3389\/fimmu.2017.01096","article-title":"Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction","volume":"8","author":"Secher","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib173","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.biopha.2017.08.117","article-title":"Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance","volume":"95","author":"Salehipour","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2024.107456_bib174","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cells9040906","article-title":"A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis","volume":"9","author":"Calvo-Barreiro","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107456_bib175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10753-020-01339-1","article-title":"Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17\/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL\/6 Mouse Model of Demyelination","volume":"44","author":"Gharehkhani Digehsara","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2024.107456_bib176","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11011-021-00857-7","article-title":"A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile","volume":"37","author":"Sadeghirashed","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2024.107456_bib177","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s12035-023-03593-4","article-title":"Bifidobacterium breve Probiotic Compared to Lactobacillus casei Causes a Better Reduction in Demyelination and Oxidative Stress in Cuprizone-Induced Demyelination Model of Rat","volume":"61","author":"Hasaniani","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107456_bib178","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ana.25244","article-title":"A probiotic modulates the microbiome and immunity in multiple sclerosis","volume":"83","author":"Tankou","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib179","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/07315724.2017.1347074","article-title":"The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"36","author":"Tamtaji","year":"2017","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2024.107456_bib180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/1028415X.2020.1758887","article-title":"Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"25","author":"Rahimlou","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib181","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/ph16101355","article-title":"Modulation of Gut Microbiome Community Mitigates Multiple Sclerosis in a Mouse Model: The Promising Role of Palmaria palmata Alga as a Prebiotic","volume":"16","author":"Yousof","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phrs.2024.107456_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2023.101794","article-title":"Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trial","volume":"53","author":"Moravejolahkami","year":"2023","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.phrs.2024.107456_bib183","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107456_bib184","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107456_bib185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.13700","article-title":"Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders","volume":"32","author":"Wilson","year":"2017","journal-title":"J. Gastro Hepatol."},{"key":"10.1016\/j.phrs.2024.107456_bib186","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods8030092","article-title":"Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications","volume":"8","author":"Davani-Davari","year":"2019","journal-title":"Foods"},{"key":"10.1016\/j.phrs.2024.107456_bib187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.03.006","article-title":"The role of prebiotics in cognition, anxiety, and depression","volume":"34","author":"Paiva","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107456_bib188","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.biopsych.2016.12.031","article-title":"Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice","volume":"82","author":"Burokas","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107456_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.537847","article-title":"The Microbiome and Alzheimer\u2019s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic Formulations","volume":"8","author":"Arora","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107456_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176016","article-title":"Feeding the gut microbiome: impact on multiple sclerosis","volume":"14","author":"Bronzini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib191","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fneur.2019.00663","article-title":"Potential of Prebiotic Butyrogenic Fibers in Parkinson\u2019s Disease","volume":"10","author":"Cantu-Jungles","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib192","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.3390\/ijms21176356","article-title":"Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism","volume":"21","author":"He","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.616883","article-title":"The Contribution of Gut Microbiota\u2013Brain Axis in the Development of Brain Disorders","volume":"15","author":"Maiuolo","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.796288","article-title":"Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging","volume":"13","author":"Mou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the Blood\u2013Brain Barrier in Multiple Sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.phrs.2024.107456_bib196","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3390\/cells12040657","article-title":"Mechanisms of Blood\u2013Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids","volume":"12","author":"Fock","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107456_bib197","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/nu14132711","article-title":"Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health","volume":"14","author":"Maiuolo","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib198","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107456_bib199","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-food-030117-012757","article-title":"Synbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities","volume":"9","author":"Krumbeck","year":"2018","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.phrs.2024.107456_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2638703","article-title":"Oxidative Stress and Dementia in Alzheimer\u2019s Patients: Effects of Synbiotic Supplementation","volume":"2020","author":"Ton","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2024.107456_bib201","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.3390\/ijms20174121","article-title":"Probiotics for Parkinson\u2019s Disease","volume":"20","author":"Gazerani","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib202","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/foods11081077","article-title":"The Concept of Postbiotics","volume":"11","author":"Vinderola","year":"2022","journal-title":"Foods"},{"key":"10.1016\/j.phrs.2024.107456_bib203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107456_bib204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/nu15020291","article-title":"Postbiotics in Human Health: A Narrative Review","volume":"15","author":"Ma","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107456_bib205","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/biom12111640","article-title":"Postbiotics and Their Health Modulatory Biomolecules","volume":"12","author":"Scott","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2024.107456_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2020.109660","article-title":"Postbiotics in human health: Possible new functional ingredients?","volume":"137","author":"Hern\u00e1ndez-Granados","year":"2020","journal-title":"Food Res. Int."},{"key":"10.1016\/j.phrs.2024.107456_bib207","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00025","article-title":"The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phrs.2024.107456_bib208","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08711-2","article-title":"The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes","volume":"10","author":"Luu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107456_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100062","article-title":"The dual effect of acetate on microglial TNF-\u03b1 production","volume":"77","author":"Fragas","year":"2022","journal-title":"Clinics"},{"key":"10.1016\/j.phrs.2024.107456_bib210","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s13311-021-01016-7","article-title":"Selected Clostridia Strains from The Human Microbiota and their Metabolite, Butyrate, Improve Experimental Autoimmune Encephalomyelitis","volume":"18","author":"Calvo-Barreiro","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2024.107456_bib211","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10753-021-01596-8","article-title":"Methyl Butyrate Alleviates Experimental Autoimmune Encephalomyelitis and Regulates the Balance of Effector T Cells and Regulatory T Cells","volume":"45","author":"Wang","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2024.107456_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.701626","article-title":"Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity via Effects on Th17 Responses","volume":"12","author":"Haase","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib213","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","article-title":"Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism","volume":"180","author":"Duscha","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107456_bib214","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ane.13045","article-title":"Short-chain fatty acids and gut microbiota in multiple sclerosis","volume":"139","author":"Melbye","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.phrs.2024.107456_bib215","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.3390\/ijms25063198","article-title":"The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis","volume":"25","author":"Barcutean","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib216","doi-asserted-by":"crossref","DOI":"10.1186\/s13317-021-00149-1","article-title":"Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?","volume":"12","author":"Becker","year":"2021","journal-title":"Autoimmun. Highlights"},{"key":"10.1016\/j.phrs.2024.107456_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104468","article-title":"Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis","volume":"129","author":"Zeng","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2024.107456_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661493","article-title":"Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls","volume":"12","author":"Olsson","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib219","article-title":"Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84881-8","article-title":"Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis","volume":"11","author":"Trend","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib221","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/ene.15150","article-title":"Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study","volume":"29","author":"Cuello","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib222","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10220","article-title":"Acetate correlates with disability and immune response in multiple sclerosis","volume":"8","author":"P\u00e9rez-P\u00e9rez","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.phrs.2024.107456_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2021.104814","article-title":"Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis","volume":"23","author":"Fettig","year":"2021","journal-title":"Microbes Infect."},{"key":"10.1016\/j.phrs.2024.107456_bib224","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107456_bib225","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/acn3.637","article-title":"Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course","volume":"5","author":"Nourbakhsh","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib226","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1756283X15607414","article-title":"Fecal microbiota transplantation: in perspective","volume":"9","author":"Gupta","year":"2016","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107456_bib227","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205064","article-title":"Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial","volume":"13","author":"Jiang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2024.107456_bib228","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/MEG.0000000000001147","article-title":"Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review","volume":"30","author":"Iqbal","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107456_bib229","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/apt.14816","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection\u2014single versus multiple infusions","volume":"48","author":"Ianiro","year":"2018","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.phrs.2024.107456_bib230","doi-asserted-by":"crossref","first-page":"10729","DOI":"10.3390\/ijms231810729","article-title":"Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases","volume":"23","author":"Belvoncikova","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib231","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.3390\/jcm12247610","article-title":"Modulating the Gut Microbiome in Multiple Sclerosis Management: A Systematic Review of Current Interventions","volume":"12","author":"Tsogka","year":"2023","journal-title":"JCM"},{"key":"10.1016\/j.phrs.2024.107456_bib232","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","article-title":"The impact of the gut microbiome on extra-intestinal autoimmune diseases","volume":"23","author":"Miyauchi","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107456_bib233","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/ijms24021001","article-title":"The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review","volume":"24","author":"Matheson","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2024.107456_bib234","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal Microbiota Transplantation in Neurological Disorders","volume":"10","author":"Vendrik","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phrs.2024.107456_bib235","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2274126","article-title":"Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis","volume":"15","author":"Kujawa","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2024.107456_bib236","article-title":"The role of the gut microbiota and fecal microbiota transplantation in neuroimmune diseases","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib237","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.3748\/wjg.v24.i37.4217","article-title":"Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome","volume":"24","author":"Camara-Lemarroy","year":"2018","journal-title":"WJG"},{"key":"10.1016\/j.phrs.2024.107456_bib238","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.710452","article-title":"Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study","volume":"8","author":"Cui","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.phrs.2024.107456_bib239","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3748\/wjg.v27.i22.2921","article-title":"Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21 st century","volume":"27","author":"El-Salhy","year":"2021","journal-title":"WJG"},{"key":"10.1016\/j.phrs.2024.107456_bib240","series-title":"T Regulatory Cells in Human Health and Diseases","first-page":"191","article-title":"The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases","author":"Liu","year":"2021"},{"key":"10.1016\/j.phrs.2024.107456_bib241","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8930813","article-title":"The Efficacy of Fecal Microbiota Transplantation in Experimental Autoimmune Encephalomyelitis: Transcriptome and Gut Microbiota Profiling","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2024.107456_bib242","first-page":"1","article-title":"Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis","volume":"2020","author":"Li","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2024.107456_bib243","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12967-021-02995-z","article-title":"Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"19","author":"Lin","year":"2021","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2024.107456_bib244","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/0963689719873890","article-title":"The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials","volume":"28","author":"Schepici","year":"2019","journal-title":"Cell Transpl."},{"key":"10.1016\/j.phrs.2024.107456_bib245","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fneur.2020.00978","article-title":"Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis","volume":"11","author":"Engen","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2024.107456_bib246","article-title":"Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial","volume":"8","author":"Al","year":"2022","journal-title":"Mult. Scler. J. - Exp., Transl. Clin."},{"key":"10.1016\/j.phrs.2024.107456_bib247","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.3390\/jcm10215077","article-title":"The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): Current Evidence and Potential Therapeutic Applications","volume":"10","author":"Varesi","year":"2021","journal-title":"JCM"},{"key":"10.1016\/j.phrs.2024.107456_bib248","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coph.2018.08.012","article-title":"Fecal microbiota transfer for bowel disorders: efficacy or hype?","volume":"43","author":"Schmulson","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107456_bib249","doi-asserted-by":"crossref","first-page":"231","DOI":"10.9758\/cpn.2016.14.3.231","article-title":"Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders","volume":"14","author":"Evrensel","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.phrs.2024.107456_bib250","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.574533","article-title":"Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update","volume":"11","author":"Tan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107456_bib251","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5946\/ce.2015.117","article-title":"Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives","volume":"49","author":"Choi","year":"2016","journal-title":"Clin. Endosc."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T19:57:35Z","timestamp":1731009455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824004018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":251,"alternative-id":["S1043661824004018"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107456","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107456"}}